104
Active Trials
32
Phase 1
22
Phase 2
50
Phase 3
13
Therapeutic Areas
Oncology
49 active / 126 total
SCLC
10 active
2 Ph3
12 total since 2015
Solid Tumor (Advanced)
9 active
17 total since 2015
NSCLC
6 active
4 Ph3
11 total since 2015
Prostate Cancer
6 active
2 Ph3
10 total since 2015
ALL
5 active
2 Ph3
12 total since 2015
Lung Cancer (General)
3 active
2 Ph3
4 total since 2015
Gastric Cancer
3 active
2 Ph3
3 total since 2015
Colorectal Cancer
2 active
2 Ph3
4 total since 2015
Sarcoma
2 active
2 total since 2015
Melanoma
1 active
1 Ph3
7 total since 2015
Pancreatic Cancer
1 active
2 total since 2015
Esophageal Cancer
1 active
2 total since 2015
Multiple Myeloma
0 active
15 total since 2015
Non-Hodgkin Lymphoma
0 active
7 total since 2015
AML
0 active
6 total since 2015
MDS
0 active
3 total since 2015
Hematologic Malignancies
0 active
2 total since 2015
Hodgkin Lymphoma
0 active
2 total since 2015
Ovarian Cancer
0 active
1 total since 2015
Glioblastoma
0 active
1 total since 2015
Hepatocellular Carcinoma
0 active
1 total since 2015
Triple Negative Breast Cancer
0 active
1 total since 2015
Head and Neck Cancer
0 active
1 total since 2015
Immunology
31 active / 109 total
Ankylosing Spondylitis
16 active
11 Ph3
33 total since 2015
Rheumatoid Arthritis
6 active
3 Ph3
27 total since 2015
Lupus
3 active
2 Ph3
13 total since 2015
Psoriasis
2 active
2 Ph3
17 total since 2015
Atopic Dermatitis
2 active
2 Ph3
12 total since 2015
Psoriatic Arthritis
2 active
2 Ph3
4 total since 2015
Ulcerative Colitis
0 active
3 total since 2015
Metabolic
12 active / 37 total
Cardiovascular
5 active / 27 total
Musculoskeletal
4 active / 16 total
CNS
2 active / 19 total
Respiratory
2 active / 3 total
Renal
1 active / 6 total
Rare Disease
1 active / 4 total
Urology
0 active / 6 total
Dermatology
0 active / 2 total
Ophthalmology
0 active / 1 total
Infectious Disease
0 active / 1 total
Click an indication to see competitive landscape (all sponsors in that indication).
Data: ClinicalTrials.gov (2015+)